Abstract
Rationale
The mechanisms underlying major depressive disorder (MDD) in children and adolescents are unclear. Metabolomics has been utilized to capture metabolic signatures of various psychiatric disorders; however, urinary metabolic profile of MDD in children and adolescents has not been studied.
Objectives
We analyzed urinary metabolites in children and adolescents with MDD to identify potential biomarkers and metabolic signatures.
Methods
Here, liquid chromatography-mass spectrometry was used to profile metabolites in urine samples from 192 subjects, comprising 80 individuals with antidepressant-naïve MDD (AN-MDD), 37 with antidepressant-treated MDD (AT-MDD) and 75 healthy controls (HC). We performed orthogonal partial least squares discriminant analysis to identify differential metabolites and employed logistic regression and receiver operating characteristic analysis to establish a diagnostic panel.
Results
In total, 143 and 71 differential metabolites were identified in AN-MDD and AT-MDD, respectively. These were primarily linked to lipid metabolism, molecular transport, and small molecule biochemistry. AN-MDD additionally exhibited dysregulated amino acid metabolism. Compared to HC, a diagnostic panel of seven metabolites displayed area under the receiver operating characteristic curves of 0.792 for AN-MDD, 0.828 for AT-MDD, and 0.799 for all MDD. Furthermore, the urinary metabolic profiles of children and adolescents with MDD significantly differed from those of adult MDD.
Conclusions
Our research suggests dysregulated amino acid metabolism and lipid metabolism in the urine of children and adolescents with MDD, similar to results in plasma metabolomics studies. This contributes to the comprehension of mechanisms underlying children and adolescents with MDD.
Similar content being viewed by others
References
Al Shweiki MR, Oeckl P, Steinacker P, Hengerer B, Schönfeldt-Lecuona C, Otto M (2017) Major depressive disorder: insight into candidate cerebrospinal fluid protein biomarkers from proteomics studies. Expert Rev Proteomics 14:499–514
Belenky P, Bogan KL, Brenner C (2007) NAD+ metabolism in health and disease. Trends Biochem Sci 32:12–19
Bouatra S, Aziat F, Mandal R, Guo AC, Wilson MR, Knox C, Bjorndahl TC, Krishnamurthy R, Saleem F, Liu P, Dame ZT, Poelzer J, Huynh J, Yallou FS, Psychogios N, Dong E, Bogumil R, Roehring C, Wishart DS (2013) The human urine metabolome. PLoS ONE 8:e73076
Bromet E, Andrade LH, Hwang I, Sampson NA, Alonso J, de Girolamo G, de Graaf R, Demyttenaere K, Hu C, Iwata N, Karam AN, Kaur J, Kostyuchenko S, Lépine JP, Levinson D, Matschinger H, Mora ME, Browne MO, Posada-Villa J, Viana MC, Williams DR, Kessler RC (2011) Cross-national epidemiology of DSM-IV major depressive episode. BMC Med 9:90
Chambers MC, Maclean B, Burke R, Amodei D, Ruderman DL, Neumann S, Gatto L, Fischer B, Pratt B, Egertson J, Hoff K, Kessner D, Tasman N, Shulman N, Frewen B, Baker TA, Brusniak MY, Paulse C, Creasy D, Flashner L, Kani K, Moulding C, Seymour SL, Nuwaysir LM, Lefebvre B, Kuhlmann F, Roark J, Rainer P, Detlev S, Hemenway T, Huhmer A, Langridge J, Connolly B, Chadick T, Holly K, Eckels J, Deutsch EW, Moritz RL, Katz JE, Agus DB, MacCoss M, Tabb DL, Mallick P (2012) A cross-platform toolkit for mass spectrometry and proteomics. Nat Biotechnol 30:918–920
Chen JJ, Liu Z, Fan SH, Yang DY, Zheng P, Shao WH, Qi ZG, Xu XJ, Li Q, Mu J, Yang YT, Xie P (2014) Combined application of NMR- and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder. Sci Rep 4:5855
Chen JJ, Xie J, Li WW, Bai SJ, Wang W, Zheng P, Xie P (2019a) Age-specific urinary metabolite signatures and functions in patients with major depressive disorder. Aging (Albany N Y) 11:6626–6637
Chen JJ, Xie J, Zeng L, Zhou CJ, Zheng P, Xie P (2019b) Urinary metabolite signature in bipolar disorder patients during depressive episode. Aging (Albany N Y) 11:1008–1018
Chen DT, Cheng SW, Chen T, Chang JP, Hwang BF, Chang HH, Chuang EY, Chen CH, Su KP (2022) Identification of genetic variations in the NAD-related pathways for patients with major depressive disorder: a case-control study in Taiwan. J Clin Med 11(13):3622. https://doi.org/10.3390/jcm11133622
Cummings CM, Caporino NE, Kendall PC (2014) Comorbidity of anxiety and depression in children and adolescents: 20 years after. Psychol Bull 140:816–845
de Villiers M, Macuamule C, Spry C, Hyun YM, Strauss E, Saliba KJ (2013) Structural modification of pantothenamides counteracts degradation by pantetheinase and improves antiplasmodial activity. ACS Med Chem Lett 4:784–789
Dunn WB, Broadhurst D, Begley P, Zelena E, Francis-McIntyre S, Anderson N, Brown M, Knowles JD, Halsall A, Haselden JN, Nicholls AW, Wilson ID, Kell DB, Goodacre R (2011) Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nat Protoc 6:1060–1083
Feng Y, Gao X, Meng M, Xue H, Qin X (2020) Multi-omics reveals the mechanisms of antidepressant-like effects of the low polarity fraction of Bupleuri Radix. J Ethnopharmacol 256:112806
Fiehn O, Robertson D, Griffin J, van der Werf M, Nikolau B, Morrison N, Sumner LW, Goodacre R, Hardy NW, Taylor C, Fostel J, Kristal B, Kaddurah-Daouk R, Mendes P, van Ommen B, Lindon JC, Sansone SA (2007) The metabolomics standards initiative (MSI). Metabolomics 3:175–178
Francklyn CS, Mullen P (2019) Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics. J Biol Chem 294:5365–5385
Gevi F, Zolla L, Gabriele S, Persico AM (2016) Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism. Mol Autism 7:47
Hankin BL, Young JF, Abela JR, Smolen A, Jenness JL, Gulley LD, Technow JR, Gottlieb AB, Cohen JR, Oppenheimer CW (2015) Depression from childhood into late adolescence: Influence of gender, development, genetic susceptibility, and peer stress. J Abnorm Psychol 124:803–816
Hawton K, van Heeringen K (2009) Suicide. Lancet 373:1372–1381
Hazell P (2002) Depression in children. BMJ 325:229–230
Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M (2014) Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res 42:D199-205
Kell DB (2004) Metabolomics and systems biology: making sense of the soup. Curr Opin Microbiol 7:296–307
Kessler RC, Bromet EJ (2013) The epidemiology of depression across cultures. Annu Rev Public Health 34:119–138
Khamis MM, Adamko DJ, El-Aneed A (2017) Mass spectrometric based approaches in urine metabolomics and biomarker discovery. Mass Spectrom Rev 36:115–134
Krämer A, Green J, Pollard J Jr, Tugendreich S (2014) Causal analysis approaches in ingenuity pathway analysis. Bioinformatics 30:523–530
Liu X, Zheng P, Zhao X, Zhang Y, Hu C, Li J, Zhao J, Zhou J, Xie P, Xu G (2015) Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry. J Proteome Res 14:2322–2330
Liu X, Liu C, Tian J, Gao X, Li K, Du G, Qin X (2020) Plasma metabolomics of depressed patients and treatment with Xiaoyaosan based on mass spectrometry technique. J Ethnopharmacol 246:112219
Liu X, Wu X, Wang S, Zhao Z, Jian C, Li M, Qin X (2023) Microbiome and metabolome integrally reveal the anti-depression effects of Cistanche deserticola polysaccharides from the perspective of gut homeostasis. Int J Biol Macromol 245:125542
Lundervold AJ, Hinshaw SP, Sørensen L, Posserud MB (2016) Co-occurring symptoms of attention deficit hyperactivity disorder (ADHD) in a population-based sample of adolescents screened for depression. BMC Psychiatry 16:46
Ma WN, Zhou MM, Gou XJ, Zhao L, Cen F, Xu Y, Shen HY (2018) Urinary metabolomic study of chlorogenic acid in a rat model of chronic sleep deprivation using gas chromatography-mass spectrometry. Int J Genomics 2018:1361402
Manning BD, Toker A (2017) AKT/PKB signaling: navigating the network. Cell 169:381–405
Miller L, Campo JV (2021) Depression in adolescents. N Engl J Med 385:445–449
Mullen S (2018) Major depressive disorder in children and adolescents. Ment Health Clin 8:275–283
Oliveira S, Ardais AP, Bastos CR, Gazal M, Jansen K, de Mattos SL, da Silva RA, Kaster MP, Lara DR, Ghisleni G (2019) Impact of genetic variations in ADORA2A gene on depression and symptoms: a cross-sectional population-based study. Purinergic Signal 15:37–44
O’Sullivan A, Gibney MJ, Brennan L (2011) Dietary intake patterns are reflected in metabolomic profiles: potential role in dietary assessment studies. Am J Clin Nutr 93:314–321
Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M, Gauthier C, Jacques P, Li S, Xia J (2021) MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res 49:W388-w396
Pu J, Liu Y, Gui S, Tian L, Yu Y, Wang D, Zhong X, Chen W, Chen X, Chen Y, Chen X, Gong X, Liu L, Li W, Wang H, Xie P (2022) Effects of pharmacological treatment on metabolomic alterations in animal models of depression. Transl Psychiatry 12:175
Regier DA, Narrow WE, Kuhl EA, Kupfer DJ (2009) The conceptual development of DSM-V. Am J Psychiatry 166:645–650
Rinschen MM, Ivanisevic J, Giera M, Siuzdak G (2019) Identification of bioactive metabolites using activity metabolomics. Nat Rev Mol Cell Biol 20:353–367
Savitz J (2020) The kynurenine pathway: a finger in every pie. Mol Psychiatry 25:131–147
Shen X, Zhu ZJ (2019) MetFlow: an interactive and integrated workflow for metabolomics data cleaning and differential metabolite discovery. Bioinformatics 35:2870–2872
Shen X, Wang R, Xiong X, Yin Y, Cai Y, Ma Z, Liu N, Zhu ZJ (2019) Metabolic reaction network-based recursive metabolite annotation for untargeted metabolomics. Nat Commun 10:1516
Sinclair E, Trivedi DK, Sarkar D, Walton-Doyle C, Milne J, Kunath T, Rijs AM, de Bie RMA, Goodacre R, Silverdale M, Barran P (2021) Metabolomics of sebum reveals lipid dysregulation in Parkinson’s disease. Nat Commun 12:1592
Smith CA, Want EJ, O’Maille G, Abagyan R, Siuzdak G (2006) XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal Chem 78:779–787
Stringaris A (2017) Editorial: What is depression? J Child Psychol Psychiatry 58:1287–1289
Thapar A, Collishaw S, Pine DS, Thapar AK (2012) Depression in adolescence. Lancet 379:1056–1067
The L (2019) ICD-11. Lancet 393:2275
Thor P, Vermandele F, Bailey A, Guscelli E, Loubet-Sartrou L, Dupont S, Calosi P (2022) Ocean acidification causes fundamental changes in the cellular metabolism of the Arctic copepod Calanus glacialis as detected by metabolomic analysis. Sci Rep 12:22223
Weckwerth W (2010) Metabolomics: an integral technique in systems biology. Bioanalysis 2:829–836
Wishart DS (2008) Metabolomics: applications to food science and nutrition research. Trends Food Sci Technol 19:482–493
Wishart DS (2019) Metabolomics for investigating physiological and pathophysiological processes. Physiol Rev 99:1819–1875
Wishart DS, Feunang YD, Marcu A, Guo AC, Liang K, Vázquez-Fresno R, Sajed T, Johnson D, Li C, Karu N, Sayeeda Z, Lo E, Assempour N, Berjanskii M, Singhal S, Arndt D, Liang Y, Badran H, Grant J, Serra-Cayuela A, Liu Y, Mandal R, Neveu V, Pon A, Knox C, Wilson M, Manach C, Scalbert A (2018) HMDB 4.0: the human metabolome database for 2018. Nucleic Acids Res 46:D608-d617
World Health O (2014) Health for the world’s adolescents: a second chance in the second decade: summary. World Health Organization, Geneva
World Medical A (2001) World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. Bull WHO 79:373–374
Yang J, Chen T, Sun L, Zhao Z, Qi X, Zhou K, Cao Y, Wang X, Qiu Y, Su M, Zhao A, Wang P, Yang P, Wu J, Feng G, He L, Jia W, Wan C (2013) Potential metabolite markers of schizophrenia. Mol Psychiatry 18:67–78
Yang L, Yu QT, Ge YZ, Zhang WS, Fan Y, Ma CW, Liu Q, Qi LW (2016) Distinct urine metabolome after Asian ginseng and American ginseng intervention based on GC-MS metabolomics approach. Sci Rep 6:39045
Yang J, Zheng P, Li Y, Wu J, Tan X, Zhou J, Sun Z, Chen X, Zhang G, Zhang H, Huang Y, Chai T, Duan J, Liang W, Yin B, Lai J, Huang T, Du Y, Zhang P, Jiang J, Xi C, Wu L, Lu J, Mou T, Xu Y, Perry SW, Wong ML, Licinio J, Hu S, Wang G, Xie P (2020) Landscapes of bacterial and metabolic signatures and their interaction in major depressive disorders. Sci Adv 6(49):eaba8555. https://doi.org/10.1126/sciadv.aba8555
Zhang W, Liu HT (2002) MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res 12:9–18
Zheng P, Chen JJ, Huang T, Wang MJ, Wang Y, Dong MX, Huang YJ, Zhou LK, Xie P (2013) A novel urinary metabolite signature for diagnosing major depressive disorder. J Proteome Res 12:5904–5911
Zheng P, Fang Z, Xu XJ, Liu ML, Du X, Zhang X, Wang H, Zhou J, Xie P (2016) Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells. J Affect Disord 195:75–81
Zhou X, Liu L, Lan X, Cohen D, Zhang Y, Ravindran AV, Yuan S, Zheng P, Coghill D, Yang L, Hetrick SE, Jiang X, Benoliel JJ, Cipriani A, Xie P (2019) Polyunsaturated fatty acids metabolism, purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents. Mol Psychiatry 24:1478–1488
Zhou Z, Luo M, Zhang H, Yin Y, Cai Y, Zhu ZJ (2022) Metabolite annotation from knowns to unknowns through knowledge-guided multi-layer metabolic networking. Nat Commun 13:6656
Acknowledgements
We gratefully acknowledge the staff from the Department of Psychiatry and the Health Management Center, the First Affiliated Hospital of Chongqing Medical University (Chongqing, China), for their contributions to subject recruitment and sample collection.
Funding
This research was financially supported by the Major Program of Brain Science and Brain-Like Intelligence Technology (Grant No. 2022ZD0212900 to XZ), the National Natural Science Foundation of China (Grant No. 82271565 to XZ), the institutional funds from the Chongqing Science and Technology Commission (Grant No. cstc2020jcyj-jqX0024 to XZ), Shanghai Municipal Science and Technology Major Project (Grant No. 2019SHZDZX02 to ZZ), Shanghai Key Laboratory of Aging Studies (Grant No. 19DZ2260400 to ZZ), the Postdoctoral Fellowship Program of China Postdoctoral Science Foundation (Grant No. GZB20230916 to TT), and the Postdoctoral Fellowship Program of China Postdoctoral Science Foundation (Grant No. 2023TQ0398 to TT).
Author information
Authors and Affiliations
Contributions
XZ, ZZ, and YJ designed the research. YJ, TT, XW, XML, YY, XEL, JW, HW, and YH recruited subjects. ZZ, YJ, YC, TT, and BY analyzed the data. XZ, YJ, YC, and TT drafted the manuscript. XZ, and ZZ supervised the project. All authors contributed to the article and approved the submitted version.
Corresponding authors
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Xinyu Zhou and Zheng-Jiang Zhu jointly supervised this work.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jiang, Y., Cai, Y., Teng, T. et al. Dysregulations of amino acid metabolism and lipid metabolism in urine of children and adolescents with major depressive disorder: a case-control study. Psychopharmacology (2024). https://doi.org/10.1007/s00213-024-06590-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00213-024-06590-0